Heart Failure Clinics

Papers
(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Obesity-Related Heart Failure with Preserved Ejection Fraction37
Hypertrophic Cardiomyopathy in RASopathies33
Exercise-Based Cardiac Rehabilitation Programs in Heart Failure Patients21
Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure20
Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction19
Advanced Heart Failure18
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy18
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease18
Left Ventricular Assist Device17
Palliative Care in Patients with Advanced Heart Failure17
Pathophysiology of Heart Failure with Preserved Ejection Fraction16
The Risk of Sudden Unexpected Cardiac Death in Children16
Exercise Intolerance in Heart Failure with Preserved Ejection Fraction15
Clinical Manifestations of 22q11.2 Deletion Syndrome15
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia14
Inotropes in Patients with Advanced Heart Failure14
Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction14
Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis14
Congestion in Patients with Advanced Heart Failure13
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis12
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia12
Clinical Practice Guidelines in Cardio-Oncology11
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure11
Addressing Comorbidities in Heart Failure11
Cardiovascular Involvement in mtDNA Disease11
Obesity and Heart Failure with Preserved Ejection Fraction10
Pulmonary Embolism10
Biomarkers in Heart Failure10
Spontaneous Coronary Artery Dissection10
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies9
Pathophysiology of Advanced Heart Failure9
SGLT2 Inhibitors and Safety in Older Patients9
Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure9
Role of Cardiac Rehabilitation After Ventricular Assist Device Implantation9
Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction8
Acute Aortic Syndromes8
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction8
Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure8
Genetics in Congenital Heart Diseases8
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis8
Role of Cardiac Magnetic Resonance Imaging in Heart Failure7
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care7
Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology7
Anemia and Management of Heart Failure Patients7
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome6
Advanced Heart Failure in Special Population6
Advanced Heart Failure in Special Population—Pediatric Age6
SGLT2 Inhibitors in Heart Failure6
Defragmenting Heart Failure Care6
Right Heart Catheterization in Patients with Advanced Heart Failure5
Cardiac Resynchronization Therapy and Cardiac Contractility Modulation in Patients with Advanced Heart Failure5
Machine Learning in Cardiovascular Imaging5
The Risk of Sudden Death in Children with Hypertrophic Cardiomyopathy5
Empowering People Living with Heart Failure5
The Role of Cardiovascular MRI in Cardio-Oncology5
Cardiovascular Magnetic Resonance of Myocardial Fibrosis, Edema, and Infiltrates in Heart Failure5
Assessment of Pericardial Disease with Cardiovascular MRI5
Using Artificial Intelligence to Better Predict and Develop Biomarkers5
Valvular Disease and Heart Failure with Preserved Ejection Fraction5
Systematizing Heart Failure Population Health5
Hypertension and Heart Failure with Preserved Ejection Fraction5
Cardiac Mechanoenergetics in Patients with Acute Myocardial Infarction5
Imaging Cardiovascular Emergencies4
Measuring Myocardial Energetics with Cardiovascular Magnetic Resonance Spectroscopy4
Acute Decompensated Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction4
Renoprotective Effects of SGLT2 Inhibitors4
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management4
Cardiac Amyloidosis4
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension4
SGLT2 Inhibitors and Peripheral Vascular Events4
Stage A Heart Failure4
Sleep Disorder and Heart Failure with Preserved Ejection Fraction4
Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction4
Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 20194
Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction4
Clinical Application of Stress Echocardiography in Management of Heart Failure4
Comprehensive Assessment of Heart Failure with Preserved Ejection Fraction Using Cardiac MRI4
Magnetic Resonance-Based Characterization of Myocardial Architecture4
Myocarditis Following COVID-19 Vaccination4
0.025483131408691